Clinical Trials Directory

Trials / Completed

CompletedNCT01079208

Growth of Infants Fed New Starter Formula

Assessment of Growth of Infants Fed Starter Formulas With Modified Protein and Synbiotics

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
297 (estimated)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
11 Days – 6 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the growth of infants fed a novel starter formula containing synbiotics and different protein levels, compared to a standard starter infant formula, during the first four months of life.

Detailed description

Breastfeeding represents the "gold standard" for infant health, and efforts are being made to support breast feeding at both the international and local levels. After breast milk, infant formulas are the next best source of nutrition for newborn and growing infants. Science and industry are striving to develop formulas that mimic as close as possible the physiological responses to human milk. There are a multitude of factors that make human milk the physiologically ideal for the infant. Among these, two important factors are the level of protein and the presence of pre-and probiotics in breast milk. The purpose of this study will be to evaluate growth of healthy infants fed a partially hydrolyzed whey protein formula with a level of protein closer to breast milk, with or without synbiotics, during the first four months of life as compared to the growth of infants fed a partially hydrolyzed whey protein formula with a standard protein level (standard formula). Additionally, the infant's digestive tolerance of the starter formula and frequency of morbidity will be investigated until 6 months of age.

Conditions

Interventions

TypeNameDescription
OTHERtest starter infant formulainfants are fed for 6 months with this starter formula
OTHERtest starter infant formula with synbioticsinfant are fed for 6 months with this formula
OTHERcontrol standard formulainfant are fed 6 months with this formula

Timeline

Start date
2010-03-01
Primary completion
2013-12-01
Completion
2014-10-01
First posted
2010-03-03
Last updated
2014-12-03

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01079208. Inclusion in this directory is not an endorsement.